DUALITYBIO-B Submits Application for A-Share Listing on Shanghai's STAR Market

Stock News

06/12

In a recent announcement, DUALITYBIO-B (09606) disclosed that it has submitted the necessary application materials to the Shanghai Stock Exchange for its proposed issuance of Renminbi-denominated shares.

The application package includes the draft prospectus for the initial public offering of ordinary A-shares and their intended listing on the Science and Technology Innovation Board, commonly known as the STAR Market.

The company has confirmed receipt of an official acceptance notice from the Shanghai Stock Exchange in response to its application for the Renminbi share issuance.

The full A-share prospectus will be made available for public viewing on the official website of the Shanghai Stock Exchange.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1137683830"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1137683830\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1137683830?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-12 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137683830","market":"hk","top_or_hot":-1,"title":"DUALITYBIO-B Submits Application for A-Share Listing on Shanghai's STAR Market","media":"Stock News","content":"<p>In a recent announcement, <b>DUALITYBIO-B</b> (<b>09606</b>) disclosed that it has submitted the necessary application materials to the Shanghai Stock Exchange for its proposed issuance of Renminbi-denominated shares.<br><br>The application package includes the draft prospectus for the initial public offering of ordinary A-shares and their intended listing on the Science and Technology Innovation Board, commonly known as the STAR Market.<br><br>The company has confirmed receipt of an official acceptance notice from the Shanghai Stock Exchange in response to its application for the Renminbi share issuance.<br><br>The full A-share prospectus will be made available for public viewing on the official website of the Shanghai Stock Exchange.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DUALITYBIO-B Submits Application for A-Share Listing on Shanghai's STAR Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDUALITYBIO-B Submits Application for A-Share Listing on Shanghai's STAR Market\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-06-12 22:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>In a recent announcement, <b>DUALITYBIO-B</b> (<b>09606</b>) disclosed that it has submitted the necessary application materials to the Shanghai Stock Exchange for its proposed issuance of Renminbi-denominated shares.<br><br>The application package includes the draft prospectus for the initial public offering of ordinary A-shares and their intended listing on the Science and Technology Innovation Board, commonly known as the STAR Market.<br><br>The company has confirmed receipt of an official acceptance notice from the Shanghai Stock Exchange in response to its application for the Renminbi share issuance.<br><br>The full A-share prospectus will be made available for public viewing on the official website of the Shanghai Stock Exchange.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_CNH","symbol_name":"HK人民幣","start_time":0,"source_url":"","article_id":"1137683830","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137683830","pubTimestamp":1781274859,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"In a recent announcement, DUALITYBIO-B (09606) disclosed that it has submitted the necessary application materials to the Shanghai Stock Exchange for its proposed issuance of Renminbi-denominated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","09606":"映恩生物-B","BK1161":"生物科技","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","CYB":"人民币ETF-WisdomTree Dreyfus"},"translate_title":"DUALITYBIO-B提交上海科创板A股上市申请","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1,"UCmain":1,"MUCmain":1,"CYB":1,"CNHmain":1,"MCNHmain":1},"content_text":"In a recent announcement, DUALITYBIO-B (09606) disclosed that it has submitted the necessary application materials to the Shanghai Stock Exchange for its proposed issuance of Renminbi-denominated shares.The application package includes the draft prospectus for the initial public offering of ordinary A-shares and their intended listing on the Science and Technology Innovation Board, commonly known as the STAR Market.The company has confirmed receipt of an official acceptance notice from the Shanghai Stock Exchange in response to its application for the Renminbi share issuance.The full A-share prospectus will be made available for public viewing on the official website of the Shanghai Stock Exchange.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}